Cargando…
Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype
INTRODUCTION: Stage IV large cell neuroendocrine carcinoma (LCNEC) of the lung generally presents as disseminated and aggressive disease with a Ki-67 proliferation index (PI) 40–80%. LCNEC can be subdivided in two main subtypes: the first harboring TP53/RB1 mutations (small-cell lung carcinoma (SCLC...
Autores principales: | Hermans, B C M, Derks, J L, Groen, H J M, Stigt, J A, van Suylen, R J, Hillen, L M, van den Broek, E C, Speel, E J M, Dingemans, A-M C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933830/ https://www.ncbi.nlm.nih.gov/pubmed/31751303 http://dx.doi.org/10.1530/EC-19-0372 |
Ejemplares similares
-
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
por: Derks, Jules L., et al.
Publicado: (2017) -
Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
por: Derks, Jules L, et al.
Publicado: (2019) -
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018) -
In‐depth molecular analysis of combined and co‐primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma
por: Hermans, Bregtje C. M., et al.
Publicado: (2021) -
Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors
por: van Adrichem, R C S, et al.
Publicado: (2013)